We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Finalizes Guidance on Postmarketing Safety Reporting for Combination Products
FDA Finalizes Guidance on Postmarketing Safety Reporting for Combination Products
The FDA has outlined the ways companies are expected to comply with postmarketing safety reporting (PMSR) requirements for combination products in final guidance issued Monday.